STAT

Is sexual desire a medical issue? An experimental drug for women revives an intense debate

In the coming days, the FDA will decide whether to approve a drug meant to increase women’s drive for sex. Not everyone is convinced the agency should.

Cancer therapies should shrink tumors. Diabetes treatments ought to lower blood sugar. But what should society expect from drugs for sexual desire?

In the coming days, the Food and Drug Administration will decide whether to approve an injection meant to increase women’s drive for sex. Its demonstrated effects are modest, but some doctors say the drug would meet a real need for thousands of women. Others, however, argue it is simply pharmaceutical overreach, another effort that reduces the complexity of human sexuality to a set of measurable dots on a chart.

“It’s a mismatch of models,” said Leonore Tiefer, a sex therapist who previously ran the sex and gender clinic at New York’s Montefiore Medical Center. “They want the car repair model: ‘Hello, doctor, I’ve got this carburetor

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks